Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001493152-25-017756
Filing Date
2025-10-10
Accepted
2025-10-10 16:06:00
Documents
84
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 6-K form6-k.htm   iXBRL 6-K 23858
2 EX-99.1 ex99-1.htm   iXBRL EX-99.1 1402657
3 EX-99.2 ex99-2.htm EX-99.2 225257
  Complete submission text file 0001493152-25-017756.txt   8669746

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE gnta-20250630.xsd EX-101.SCH 60072
5 XBRL CALCULATION FILE gnta-20250630_cal.xml EX-101.CAL 61522
6 XBRL DEFINITION FILE gnta-20250630_def.xml EX-101.DEF 261461
7 XBRL LABEL FILE gnta-20250630_lab.xml EX-101.LAB 434954
8 XBRL PRESENTATION FILE gnta-20250630_pre.xml EX-101.PRE 362607
88 EXTRACTED XBRL INSTANCE DOCUMENT form6-k_htm.xml XML 1791324
Mailing Address OLGETTINA, NO. 58 MILAN L6 20132
Business Address OLGETTINA, NO. 58 MILAN L6 20132 39-02-2643-6639
Genenta Science S.p.A. (Filer) CIK: 0001838716 (see all company filings)

EIN.: 000000000 | State of Incorp.: L6
Type: 6-K | Act: 34 | File No.: 001-41115 | Film No.: 251388160
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)